•  •  Dark Mode

Your Interests & Preferences

I am a...

law firm lawyer
in-house company lawyer
litigation lawyer
law student
aspiring student

Website Look & Feel

 •  •  Dark Mode
Blog Layout

Save preferences

Khaitan acts for Bharat Serums & Vaccines on sale to Advent PE

Private equity firm Advent International (Advent) has signed a definitive agreement to acquire a majority interest in Bharat Serums and Vaccines Limited for an undisclosed sum. Bharat Serums is a biopharmaceutical player in women’s healthcare, assisted reproductive treatment, critical care and emergency medicine in India and emerging markets.
Business Standard

Khaitan & Co advised Bharat Serums and Vaccines Limited and its promoters, the Daftary family, led by a core transaction team of partner Haigreve Khaitan, partner Sameer Sah, senior associate Ayush Nanda and associate Aman Anand, also with assistance from the following: corporate aspects principal associate Purti Minawala, senior associate Avantika Govil, associate Kanika Mathew, associate Maitreya Subramaniam and consultant Subramanian Ramaswamy; employment aspects partner Anshul Prakash, principal associate Deepak Kumar, associate Abhisek Choudhury, associate Deeksha Malik and associate Kosheel Gupta; litigation aspects principal associate Manavendra Mishra and senior associate Zacarias Joseph; real estate aspects partner Harsh Parikh and principal associate Abhiraj Gandhi.


Deal value: Confidential

This deal report is based on a firm's press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.

Click to show 1 comment
at your own risk
By reading the comments you agree that they are the (often anonymous) personal views and opinions of readers, which may be biased and unreliable, and for which Legally India therefore has no liability. If you believe a comment is inappropriate, please click 'Report to LI' below the comment and we will review it as soon as practicable.